Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Germany

European Research Council grant · Running

RESOLVE Nonresolving inflammation in demyelinating disorders

Coordinator
Technische Universitaet Muenchen, Germany
Runs
1 January 2027 to 31 December 2031
Status
Running
EU funding
€2.5m
Total cost
—
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101264099

What the project is doing

In the project's own words, from its summary on CORDIS.

Myelin is essential for nervous system function, and its loss, as observed in demyelinating diseases, disrupts axonal conduction and contributes to neurodegeneration. This proposal focuses on demyelinating conditions in which injury to oligodendrocytes or myelin initiates tissue damage and activates an innate immune response. While this response can support remyelination, in certain pathological contexts, the process can become dysregulated.

This leads to persistent, non-resolving inflammation that impairs remyelination and promotes neurodegeneration. A key objective of this proposal is to elucidate how the response transitions from a self-limiting, regenerative response to a chronic, self-sustaining pathological state. I hypothesize that one key driver of this transition lies in the decline of metabolic recycling functions in microglia. Specifically, I propose that immune signaling can disrupt recycling of cholesterol and iron, triggering a maladaptive cascade.

Moreover, I suggest that aberrant communication between microglia and oligodendrocytes forms a pathological feedback loop that perpetuates chronic inflammation. To investigate these mechanisms, I propose a research program focused on uncovering the fundamental biology of tissue injury responses and their progression to chronic, non-resolving inflammation. Combining genetics, glial biology, neuroimmunology, advanced imaging, and biochemistry, we will systematically examine how innate immune and metabolic dysregulation in microglia damage oligodendrocytes and contribute to disease progression in demyelinating disorders.

Persistent inflammation is a major contributor to the global burden of neurological disease. By uncovering the mechanisms that sustain this pathological process, our research has the potential to yield transformative insights with broad relevance. This is an ambitious proposal, but if successful, it will open new avenues for targeting a shared, disease-spanning mechanism in neurology.

Who is involved

OrganisationCityCountryRole
Technische Universitaet MuenchenMuenchenGermanyCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI